ArticleCancers2026
The Combination of a BCL-xL PROTAC and an mTOR Inhibitor Sensitizes Pancreatic Ductal Adenocarcinoma to KRAS
Javed Miyan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancers2026
Javed Miyan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.